Date and Time
Boğaziçi University Kandilli Deep Tech Base, Rasathane St. N:104 D:7, 34684 Üsküdar/İstanbul
About this event
The Bogaziçi University Center for Life Sciences and Technologies (BULifeSci) launches the bi-monthly ‘Bogaziçi LifeSci Kandilli Deep Talks’ seminar series focusing on current issues and innovations in the field of health and biotechnology, for start-ups and SMEs.
‘Kandilli Deep Talks’ are organised under the scope of the “Technical Assistance for R&D Support Labs for Life Sciences SMEs towards Global Competitiveness” project, co-financed by the European Union and the Republic of Turkey under the Competitive Sectors Programme executed by the Ministry of Industry and Technology.
We kindly invite you to join the first ‘Kandilli Deep Talks’ and become a part of LifeSci’s network.
11.00 – 11.15 Welcome Speech
Prof. Cengizhan Öztürk
Industrial Projects Coordinator, Bogaziçi University Center for Life Sciences and Technologies
11.15 – 11.30 Overview on the Technical Assistance Project
Dr. Pascal Kahlem
Technical Assistance Project Team Leader
11.30 – 12.00 Development of a new type of imaging agent: From bench to bedside
Prof. Mangala Srinivas
Head of Dept. in Cell Biology and Immunology at Wageningen University & Research
12.00 – 12.15 Q&A
Simultaneous translation will be provided.
Abstract of Prof. Mangala Srinivas Presentation
Imaging agents, and nanotechnology in general, fall in a gray space in terms of clinical development. They are difficult both in terms of formulation, and also regulation, sometimes being classified as a medicinal product. In this talk, I will go over my group’s work in developing and characterising a new type of imaging agent, and the journey to the clinic. I’ll discuss the need for imaging in advanced therapies, and how this can benefit scientists. I’ll also go over some of the hurdles we encountered on our journey. Specifically, we are working with a nanoparticle, consisting of a polymer entrapped in a polymer matrix that works with several clinical and preclinical imaging modalities (MRI, ultrasound, fluorescence, PET, SPECT). The nanoparticle is designed for labeling therapeutic cells for quantitative, in vivo cell tracking, but can be adapted to several other applications.